Perry Molinoff to Humans
This is a "connection" page, showing publications Perry Molinoff has written about Humans.
Connection Strength
0.130
-
Evaluation of the safety, pharmacokinetics and pharmacodynamic effects of subcutaneously administered PT-141, a melanocortin receptor agonist, in healthy male subjects and in patients with an inadequate response to Viagra. Int J Impot Res. 2004 Apr; 16(2):135-42.
Score: 0.009
-
Double-blind, placebo-controlled evaluation of the safety, pharmacokinetic properties and pharmacodynamic effects of intranasal PT-141, a melanocortin receptor agonist, in healthy males and patients with mild-to-moderate erectile dysfunction. Int J Impot Res. 2004 Feb; 16(1):51-9.
Score: 0.009
-
PT-141: a melanocortin agonist for the treatment of sexual dysfunction. Ann N Y Acad Sci. 2003 Jun; 994:96-102.
Score: 0.008
-
Regulation of D2 and D3 receptors in transfected cells by agonists and antagonists. Adv Pharmacol. 1998; 42:443-6.
Score: 0.006
-
Agonists and antagonists differentially regulate the high affinity state of the D2L receptor in human embryonic kidney 293 cells. Mol Pharmacol. 1995 Nov; 48(5):956-64.
Score: 0.005
-
Lack of discrimination by agonists for D2 and D3 dopamine receptors. Neuropsychopharmacology. 1995 Jul; 12(4):335-45.
Score: 0.005
-
Mechanisms of up-regulation of D2L dopamine receptors by agonists and antagonists in transfected HEK-293 cells. J Pharmacol Exp Ther. 1994 Dec; 271(3):1574-82.
Score: 0.005
-
Characterization of [125I](R)-trans-7-hydroxy-2-[N-propyl-N-(3'-iodo-2'-propenyl)amino] tetralin binding to dopamine D3 receptors in rat olfactory tubercle. J Pharmacol Exp Ther. 1994 Feb; 268(2):935-42.
Score: 0.004
-
Molecular pharmacology of NMDA receptors: modulatory role of NR2 subunits. Prog Brain Res. 1994; 100:39-45.
Score: 0.004
-
Paradoxical regulation of dopamine receptors in transfected 293 cells. Mol Pharmacol. 1993 Aug; 44(2):371-9.
Score: 0.004
-
Development of polyclonal anti-D2 dopamine receptor antibodies using sequence-specific peptides. Mol Pharmacol. 1993 May; 43(5):666-76.
Score: 0.004
-
Expression and characterization of the rat D3 dopamine receptor: pharmacologic properties and development of antibodies. J Pharmacol Exp Ther. 1993 Feb; 264(2):1002-11.
Score: 0.004
-
Evolving properties of beta-adrenergic receptor antagonists. Pharmacotherapy. 1992; 12(2):144-53.
Score: 0.004
-
Developing treatments for female sexual dysfunction. Clin Pharmacol Ther. 2011 Jan; 89(1):137-41.
Score: 0.003
-
Effect of exercise duration on density and coupling of beta-adrenergic receptors on human mononuclear cells. J Appl Physiol (1985). 1989 Mar; 66(3):1494-500.
Score: 0.003
-
Mechanisms of downregulation of beta-adrenergic receptors: perspective on the role of beta-adrenergic receptors in congestive heart failure. J Cardiovasc Pharmacol. 1989; 14 Suppl 5:S13-8.
Score: 0.003
-
Characterization of binding sites for 3H-spiroperidol in human retina. Invest Ophthalmol Vis Sci. 1988 May; 29(5):687-94.
Score: 0.003
-
Distribution and properties of beta-adrenergic receptors in human iris-ciliary body. Invest Ophthalmol Vis Sci. 1987 Mar; 28(3):420-30.
Score: 0.003
-
Effects of pindolol and propranolol on beta adrenergic receptors on human lymphocytes. J Pharmacol Exp Ther. 1986 Oct; 239(1):117-23.
Score: 0.003
-
Quantitative analysis of the selectivity of radioligands for subtypes of beta adrenergic receptors. J Pharmacol Exp Ther. 1986 Jul; 238(1):46-53.
Score: 0.003
-
Effects of chronic administration of agonists and antagonists on the density of beta-adrenergic receptors. Am J Cardiol. 1986 Apr 25; 57(12):17F-22F.
Score: 0.003
-
Coexistence of beta-1 and beta-2 adrenergic receptors in the human heart: effects of treatment with receptor antagonists or calcium entry blockers. J Pharmacol Exp Ther. 1985 Sep; 234(3):561-8.
Score: 0.002
-
In vitro interactions of agonists and antagonists with beta-adrenergic receptors. Biochem Pharmacol. 1984 Mar 15; 33(6):869-75.
Score: 0.002
-
Alpha- and beta-adrenergic receptor subtypes properties, distribution and regulation. Drugs. 1984; 28 Suppl 2:1-15.
Score: 0.002
-
Decreased beta adrenergic receptor density on human lymphocytes after chronic treatment with agonists. J Pharmacol Exp Ther. 1983 Jan; 224(1):1-6.
Score: 0.002
-
Effects of drugs on beta-adrenergic receptors on human lymphocytes. J Cardiovasc Pharmacol. 1983; 5 Suppl 1:S63-7.
Score: 0.002
-
Effects of pindolol and propranolol on beta-adrenergic receptors on human lymphocytes. Br J Clin Pharmacol. 1982; 13(Suppl 2):365S.
Score: 0.002
-
Targeting acute ischemic stroke with a calcium-sensitive opener of maxi-K potassium channels. Nat Med. 2001 Apr; 7(4):471-7.
Score: 0.002
-
Beta-adrenergic receptor subtypes: properties, distribution, and regulation. Annu Rev Neurosci. 1981; 4:419-61.
Score: 0.002
-
Effects of ethanol administration and withdrawal on neurotransmitter receptor systems in C57 mice. J Pharmacol Exp Ther. 1980 Jun; 213(3):491-6.
Score: 0.002
-
Classification and quantitation of beta-adrenergic receptor subtypes. Biochem Pharmacol. 1980 May 15; 29(10):1317-23.
Score: 0.002
-
Elevation of beta-adrenergic receptor density in human lymphocytes after propranolol administration. J Clin Invest. 1980 May; 65(5):949-57.
Score: 0.002
-
Brain neurotransmitter receptor systems in alcohol treated mice and in mice genetically selected for differences in sensitivity to alcohol. Adv Exp Med Biol. 1980; 132:787-95.
Score: 0.002
-
Increased human lymphocyte beta-adrenergic receptor density following chronic propranolol treatment. Proc West Pharmacol Soc. 1979; 22:175-6.
Score: 0.002
-
5-hydroxytryptamine1A receptor-mediated increases in receptor expression and activation of nuclear factor-kappaB in transfected Chinese hamster ovary cells. Mol Pharmacol. 1997 Aug; 52(2):221-6.
Score: 0.001
-
Occurrence, transport, and storage of octopamine in human thrombocytes. Clin Pharmacol Ther. 1975 Nov; 18(5 Pt 1):587-93.
Score: 0.001
-
Expression of the human 5-hydroxytryptamine1A receptor in Sf9 cells. Reconstitution of a coupled phenotype by co-expression of mammalian G protein subunits. J Biol Chem. 1995 Aug 04; 270(31):18691-9.
Score: 0.001
-
International Union of Pharmacology nomenclature of adrenoceptors. Pharmacol Rev. 1994 Jun; 46(2):121-36.
Score: 0.001
-
The regulation of the noradrenergic neuron. J Psychiatr Res. 1974; 11:339-45.
Score: 0.001
-
Subtypes of serotonin receptors and anxiolytic drugs: model systems for the study of 5-HT receptors. Clin Neuropharmacol. 1992; 15 Suppl 1 Pt A:531A-532A.
Score: 0.001
-
Hemodynamic and beta-adrenergic receptor adaptations during long-term beta-adrenoceptor blockade. Studies with acebutolol, atenolol, pindolol, and propranolol in hypertensive patients. Circulation. 1989 Oct; 80(4):903-14.
Score: 0.001
-
New form of pseudohypoparathyroidism with abnormal catalytic adenylate cyclase. Am J Physiol. 1989 Aug; 257(2 Pt 1):E277-83.
Score: 0.001
-
Characterization of lymphocyte beta-adrenergic receptors at rest and during exercise in ambulatory patients with chronic congestive heart failure. Am J Cardiol. 1989 Feb 01; 63(5):307-12.
Score: 0.001
-
Characterization of beta-adrenergic receptors in cultured human trabecular cells and in human trabecular meshwork. Invest Ophthalmol Vis Sci. 1989 Jan; 30(1):51-7.
Score: 0.001
-
Acute and long-term effects of acebutolol on systemic and renal hemodynamics, body fluid volumes, catecholamines, active renin, aldosterone, and lymphocyte beta-adrenoceptor density. J Cardiovasc Pharmacol. 1988 Apr; 11(4):413-23.
Score: 0.001
-
Role of beta-adrenergic receptors in catecholamine-induced desensitization of adenylate cyclase in human astrocytoma cells. J Biol Chem. 1978 Mar 10; 253(5):1472-80.
Score: 0.000
-
Competitive effects of hypokalemia and volume depletion on plasma renin activity, aldosterone and catecholamine concentrations in hemodialysis patients. Kidney Int. 1977 Oct; 12(4):279-84.
Score: 0.000
-
Electrophoretic properties of dopamine -hydroxylase in several tissues from three species. Mol Pharmacol. 1972 Jan; 8(1):50-8.
Score: 0.000